Mirum Pharmaceuticals Inc Cash Flow Quality Index

Latest as of September 2025: 13.66x

Mirum Pharmaceuticals Inc cash flow quality index. Mirum Pharmaceuticals Inc (MIRM) has a Cash Flow Quality Index of 13.66x as of September 2025. Operating cash flow of $39.68 Million exceeds net income of $2.90 Million, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of Mirum Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

13.66x
Operating CF / Net Income

Operating Cash Flow

$39.68 Million
USD

Net Income

$2.90 Million
USD

Data as of

Sep 2025
Most recent filing

Mirum Pharmaceuticals Inc Cash Flow Quality Index by Year (None–None)

Mirum Pharmaceuticals Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Mirum Pharmaceuticals Inc. For the full cash flow conversion analysis, see Mirum Pharmaceuticals Inc operating cash flow efficiency.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.